Merck KGaA
MRK.DEFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
22,214
Cost of Revenue
9,105
Gross Profit
13,109
Gross Margin
59.0%
Operating Income
3,827
Operating Margin
17.2%
Net Income
2,916
Net Margin
13.1%
EPS (Basic)
$7.00
EPS (Diluted)
$7.00
EBITDA
6,260
EBITDA Margin
28.2%
2023
12/31/2023
Revenue
22,043
Cost of Revenue
9,790
Gross Profit
12,252
Gross Margin
55.6%
Operating Income
3,789
Operating Margin
17.2%
Net Income
2,965
Net Margin
13.5%
EPS (Basic)
$7.00
EPS (Diluted)
$7.00
EBITDA
5,969
EBITDA Margin
27.1%
2022
12/31/2022
Revenue
23,344
Cost of Revenue
8,953
Gross Profit
14,390
Gross Margin
61.6%
Operating Income
4,698
Operating Margin
20.1%
Net Income
3,492
Net Margin
15.0%
EPS (Basic)
$8.00
EPS (Diluted)
$8.00
EBITDA
6,593
EBITDA Margin
28.2%
2021
12/31/2021
Revenue
20,671
Cost of Revenue
7,719
Gross Profit
12,953
Gross Margin
62.7%
Operating Income
4,388
Operating Margin
21.2%
Net Income
3,208
Net Margin
15.5%
EPS (Basic)
$7.00
EPS (Diluted)
$7.00
EBITDA
6,174
EBITDA Margin
29.9%
2020
12/31/2020
Revenue
18,411
Cost of Revenue
7,177
Gross Profit
11,234
Gross Margin
61.0%
Operating Income
3,134
Operating Margin
17.0%
Net Income
2,086
Net Margin
11.3%
EPS (Basic)
$5.00
EPS (Diluted)
$5.00
EBITDA
5,014
EBITDA Margin
27.2%